2m 2m 2m 2m 2m 2m 2m
Cytosorbents (CTSO)
NASDAQ
$0.39+$0.01 (+2.63%)
Price as of Jul 14, 2026 12:33 PM EDT- $23.9MMarket Cap
- -63.81%1-Year Change
- Medical DevicesIndustry
Cytosorbents (CTSO)
$0.39+$0.01 (+2.63%)
CTSO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.38 | ||
Change | -$0.001 (-0.34%) | ||
Open | $0.39 | ||
High | $0.42 | ||
Low | $0.37 | ||
Previous Close | $0.38 | ||
Volume | 91,298 | ||
30-Day Average Volume | 228,193 | ||
1-Week Change | -11.63% | ||
1-Month Change | -4.95% | ||
1-Year Change | -63.81% | ||
3-Year Change | -90.05% | ||
5-Year Change | -95.06% | ||
Fundamentals | |||
Shares Outstanding | 62.8M | ||
Total Assets | $40.6M | ||
Market Cap | $23.9M | ||
Enterprise Value | $36.0M | ||
Period: QTR TTM FY | |||
Revenue | $8.9M | ||
Net Income | -$5.1M | ||
Free Cash Flow | -$1.2M | ||
EBIT | -$4.3M | ||
EBITDA | -$4.2M | ||
Net Working Capital | $1.5M | ||
EPS | -$0.08 | ||
Enterprise Value/EBITDA | -9 | ||
Enterprise Value/Revenue | 4 | ||
P/B | 11 | ||
P/E | -5 | ||
PEG | -0 | ||
Price/Free Cash Flow | -20 | ||
Price/Operating Cash Flow | -21 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 12/05/2014 | ||
Earnings & Revenue